WhiteLab Genomics develops software solutions leveraging machine learning and graph knowledge technology to assist in the discovery and design of genomic therapies.

WhiteLab Genomics

Google Maps

reCAPTCHA

CrUX Dataset

CrUX Top 50m

reCAPTCHA v2

WPForms

Business Development Specialist

Elizabeth Kish

Information Technology

Oscar de Felice

Scientist

Rebecca Laurent

Business Development and Marketing

Thelma Tricoire

Vincent Lepreux

Julien Cottineau

Founder and Chief Scientific Officer

David Delbourgo

CEO and co-founder

Biotechnology Companies With More Than 10 Employees (Top 10K)

European Union (EU) Startups Founded in 2019

Europe, Middle East, and Africa (EMEA) Seed Stage Companies With Fewer Than 50 Employees (Top 10K)

Europe Startups (Top 10K)

WhiteLab Genomics develops a proprietary platform that leverages graph knowledge technology and machine learning to help companies discover and design new genomic therapies. WhiteLab Genomics enables genomic medicine scientists to obtain precise and comprehensive answers to key scientific and technological questions such as optimizing payload and vector design, assessing genotoxicity, and identifying optimal experimental protocols for in vivo and in vitro strategies. Whitelab Genomics guides its clients through the in-silico development phases, allowing them to quickly develop target vectors and payloads while saving valuable time needed to provide patients with access to new genomic therapies.

Debiopharm Group

Omnes Capital

Seed Round - WhiteLab Genomics

Y Combinator

Pre Seed Round - WhiteLab Genomics

Paris

Ile-de-France

France

Europe

WhiteLab Genomics on LinkedIn: "WhiteLab Wednesdays"! Check out some behind the scenes photos of our team…

WhiteLab Genomics has officially expanded to Boston!

Alberto Nobili on LinkedIn: WhiteLab Genomics Establishes US Presence by Securing Spot at Bayer Co.Lab…

WhiteLab Genomics on LinkedIn: Meet Fanny Goretta, our new Business Development Intern! Fanny Goretta…

WhiteLab Genomics on LinkedIn: Meet Natasha Liu, WhiteLab Genomics' Talent Acquisition and Employer Brand…

Healthtech in 2023

How WhiteLab Genomics is using AI to aid gene and cell therapy development

A specialized AI platform that enables in-silico predictions for target discovery and design of DNA & RNA therapies, incorporating large curated datasets and proprietary algorithms.

A service focused on identifying potential targets for DNA and RNA therapies using advanced data science and machine learning.

A service that assists in designing the genetic payloads for DNA and RNA therapies, optimizing them for therapeutic efficacy.

A service dedicated to designing vectors for gene delivery, ensuring they are optimized for tissue targeting, immune evasion, and packaging size.

Support services provided by experts in DNA and RNA therapies, genome engineering, computational biology, and machine learning to assist customers in developing biotherapy strategies.

Collaborative opportunities with gene therapy leaders to leverage WhiteLab's platform for research and development of cell and gene therapies.

United States

North America

Switzerland

Malaysia

Asia

Belarus

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 16, 2024 3:08 PM	9a7efe76
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 16, 2024 3:08 PM	67c66712
crunchbase trigger	general	Nov 18, 2024 2:12 PM	27f5a676
crunchbase profile	general	Nov 19, 2024 1:39 AM	e06ee5e8
li profile	general
translate crunchbase fundingrounds	general	Nov 19, 2024 2:02 AM	e445c6f9
peers	general	Oct 16, 2024 3:08 PM	8f5f4696
news basic	general	Oct 16, 2024 3:08 PM	2f2de96a
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:WHITELABGX

WhiteLab Genomics